The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Breast Cancer Screen 124 Tissue Microarray - LS-SBRCA124

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SBRCA124
Product Name:	Breast Cancer Screen 124
Description:	16 invasive ductal breast carcinoma specimens with stage/grade and marker data (AR, ER, PR, HER2), and 16 matched adjacent normal/non-neoplastic breast specimens (duplicate cores)
Format:	FFPE
Category:	Human Tumor and Matched Normal
QA/QC:	H&E reviewed; IHC validated with a positive control antibody
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	Yes
Stage/Grade:	Yes
Core Diameter:	2 mm
Core Thickness:	4 µm
Cases:	16
Cores:	48
Slides Per Set:	1

LS-SBRCA124 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8
A	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
B	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
C	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
D	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
E	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst
F	Bst	Bst	Bst	Bst	Bst	Bst	Bst	Bst

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Breast (Bst);

LS-SBRCA124 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	Androgen Receptor (AR)	ERBB2 (HER2)	Estrogen Receptor (ER)	Progesterone Receptor (PR)	TNM Tumor Classification	Tumor Stage
1	A1	Human	F	28 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T1N0M0	I
1	A2	Human	F	56 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 2%	-	-	-	T1N0M0	I
1	A3	Human	F	38 y	Breast (Bst)	Infiltrating poorly differentiated carcinoma	Malignant	-	-	-	-	T4N0M0	III
1	A4	Human	F	74 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 5%	-	+++, 90%	++~+++, 20%	T2N0M0	II-III
1	A5	Human	F	33 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant		-		-	T2N0M0	III
1	A6	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	+++, 90%	+++, 60%	T2N0M0	III
1	A7	Human	F	50 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 20%	+	++~+++, 80%	+++, 90%	T2N0M0	II-III
1	A8	Human	F	40 y	Breast (Bst)	Infiltrating poorly differentiated carcinoma	Malignant	-	++~+++	-	-	T2N0M0	III
1	B1	Human	F	28 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T1N0M0	I
1	B2	Human	F	56 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 2%	-	-	-	T1N0M0	I
1	B3	Human	F	38 y	Breast (Bst)	Infiltrating poorly differentiated carcinoma	Malignant	-	-	-	-	T4N0M0	III
1	B4	Human	F	74 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 5%	-	+++, 90%	++~+++, 20%	T2N0M0	II-III
1	B5	Human	F	33 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant		-		-	T2N0M0	III
1	B6	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	++~+++	+++, 90%	+++, 60%	T2N0M0	III
1	B7	Human	F	50 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	+, 20%	+	++~+++, 80%	+++, 90%	T2N0M0	II-III
1	B8	Human	F	40 y	Breast (Bst)	Infiltrating poorly differentiated carcinoma	Malignant	-	++~+++	-	-	T2N0M0	III
1	C1	Human	F	28 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	-	-
1	C2	Human	F	56 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	++~+++, 10%	+++, 10%
1	C3	Human	F	38 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	++, 1%	++, 1%
1	C4	Human	F	74 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	+, 2%	-	+++, 20%	-
1	C5	Human	F	33 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	++, 5%	-	+++, 50%	+++, 15%
1	C6	Human	F	53 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	+++, 50%	-
1	C7	Human	F	50 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	++, 10%	-	++~+++, 20%	+++, 50%
1	C8	Human	F	40 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	++, 15%	+++, 50%
1	D1	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 5%	+	++, 10%	++, 50%	T2N0M0	II
1	D2	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 50%	+++	-	-	T2N1M0	II-III
1	D3	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T2N0M0	II-III
1	D4	Human	F	36 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 10%	+++	++, 20%	++~+++, 20%	T2N0M0	II-III
1	D5	Human	F	77 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T2N0M0	III
1	D6	Human	F	43 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	+	-	+~++, 30%	T2N0M0	II-III
1	D7	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	++~+++	++, 50%	-	T2N0M0	I-II
1	D8	Human	F	66 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	+	+++, 90%	-	T2N0M0	II-III
1	E1	Human	F	35 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 5%	+	++, 10%	++, 50%	T2N0M0	II
1	E2	Human	F	53 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 50%	+++	-	-	T2N1M0	II-III
1	E3	Human	F	47 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	+++	-	-	T2N0M0	II-III
1	E4	Human	F	36 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	++, 10%	+++	++, 20%	++~+++, 20%	T2N0M0	II-III
1	E5	Human	F	77 y	Breast (Bst)	Ductal carcinoma, infiltrating	Malignant	-	-	-	-	T2N0M0	III
1	E6	Human	F	43 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	+	-	+~++, 30%	T2N0M0	II-III
1	E7	Human	F	47 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	++~+++	++, 50%	-	T2N0M0	I-II
1	E8	Human	F	66 y	Breast (Bst)	Lobular carcinoma, infiltrating	Malignant	-	+	+++, 90%	-	T2N0M0	II-III
1	F1	Human	F	35 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	+	-	+++, 2%
1	F2	Human	F	53 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	++, 20%	+-	+++, 10%	-
1	F3	Human	F	47 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic		-	++, 5%	++, 1%
1	F4	Human	F	36 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	++, 10%	+	++, 5%	+++, 15%
1	F5	Human	F	77 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic
1	F6	Human	F	43 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	+, 5%	-	++, 5%	+++, 5%
1	F7	Human	F	47 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	+, 2%	+-	++, 5%	+++, 2%
1	F8	Human	F	66 y	Breast (Bst)	Matched adjacent normal	Benign non-neoplastic	-	-	++, 50%	++~+++, 10%

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.